The invention is directed to 4h-benzo[1,4]oxazin-3-ones useful as peroxisome proliferator activated receptor gamma (PPARγ) agonists or antagonists. Pharmaceutical compositions comprising compounds of the present invention and methods of treating conditions such as NIDDM and obesity are also disclosed.
本发明涉及作为
过氧化物酶体增殖物激活受体γ(
PPARγ)激动剂或拮抗剂的 4h-苯并[1,4]恶嗪-3-酮。本发明还公开了包含本发明化合物的药物组合物以及治疗 NID
DM 和肥胖症等疾病的方法。